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ORIGINAL INVESTIGATION
Preventing Weight Gain by Lifestyle Intervention
in a General Practice Setting
Three-Year Results of a Randomized Controlled Trial
Nancy C. W. ter Bogt, MSc; Wanda J. E. Bemelmans, PhD; Frank W. Beltman, MD, PhD;
Jan Broer, MD, PhD; Andries J. Smit, MD, PhD; Klaas van der Meer, MD, PhD
Background: Weight regain after initial loss of weight
is common, which indicates a need for lifestyle counsel-
ing aimed at preventing weight gain instead of weight loss.
This study was conducted to determine whether struc-
tured lifestyle counseling by nurse practitioners (NPs)
group compared with usual care by general practition-
ers (GP-UC) in overweight and obese patients can pre-
vent (further) weight gain.
Methods: A randomized controlled trial in 11 general
practice locations in the Netherlands of 457 patients
(body mass index, 25-40 [calculated as weight in kilo-
grams divided by height in meters squared]; mean age,
56 years; 52% female) with either hypertension or dys-
lipidemia or both. The NP group received lifestyle
counseling with guidance of the NP using a standard-
ized software program. The GP-UC group received
usual care from their GP. Main outcome measures were
changes in body weight, waist circumference, blood
pressure, and fasting glucose and blood lipid levels after
3 years.
Results: In both groups, approximately 60% of the par-
ticipants achieved weight maintenance after 3 years. There
was no significant difference in mean (SD) weight change
andchangeofwaistcircumferencebetweentheNPandGP-
UC groups (weight change: NP group, −1.2% [5.8%], and
GP-UC group, −0.6% [5.6%] [P=.37]; and change of waist
circumference:NPgroup,−0.8[7.1]cm,andGP-UCgroup,
0.4 [7.2]cm[P=.11]).Asignificantdifferenceoccurred for
mean (SD) fasting glucose levels (NP group, −0.02 [0.49]
mmol/L, and GP-UC group, 0.10 [0.53] mmol/L [P=.02])
(to convert to milligrams per deciliter, divide by 0.0555)
but not for lipid levels and blood pressure.
Conclusions: Lifestyle counseling by NPs did not lead
to significantly better prevention of weight gain com-
pared with GPs. In the majority in both groups, lifestyle
counseling succeeded in preventing (further) weight gain.
Trial Registration: trialregister.nl Identifier: NTR1365
Arch Intern Med. 2011;171(4):306-313
T HE RISING PREVALENCE OFoverweight and obesity is aworldwide problem. An in-creased body mass index(BMI) is associated with
higher mortality,1 the development of coro-
nary vascular disease (partly independent
of blood pressure [BP] and cholesterol lev-
els2), type 2 diabetes mellitus, certain types
of cancer, gastrointestinal diseases, and ar-
thritis.3 The large impact of these diseases
on shortening healthy lifespan and increas-
ing health care costs stresses the need for
strategies to tackle this problem.
Studies show that lifestyle interven-
tions (including a nutrition and physical
activity component) are needed to main-
tain or lose weight.4 Intensive lifestyle pro-
grams such as the Diabetes Prevention Pro-
gram and the Diabetes Prevention Study
showed weight losses of approximately 4
kg and 3 kg, respectively, after 3 years, ac-
companied by improvements in cardio-
vascular risk factor levels.5,6 Because weight
regain after weight loss in obese persons
is a common problem, a more successful
approach may be to prevent weight gain
and focus on weight management in those
with milder degrees of overweight. Small
changes in lifestyle can improve health sta-
tus even without losing weight7,8 and might
be easier to maintain in the long term.
The primary care setting is suitable for
weight maintenance; previous studies have
shown that lifestyle interventions in pri-
mary care can be effective, at least in the
short term.9-11 However, little is known
about long-term effects (over several years)
in this setting. Guidelines in the treat-
ment of hypertension and dyslipidemia (of-
ten accompanied by overweight and obe-
sity) for general practitioners (GPs) include
lifestyle advice,12 but in practice, compli-
ance with the lifestyle component of these
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guidelines seems limited.13 Frequently reported barriers
for lifestyle counseling by GPs include lack of time, lack
of patient compliance, insufficient knowledge about the
subject, and lack of evidence-based interventions.14 A so-
lution to some of these barriers may be to delegate life-
style counseling to nurse practitioners (NPs).
The Groningen Overweight and Lifestyle (GOAL)
study was conducted to compare the effects of struc-
tured lifestyle counseling by NPs with usual care by gen-
eral practitioners (GP-UC) on preventing weight gain and
improving health status in overweight and obese pa-
tients with either hypertension, dyslipidemia, or both.
Short-term, 1-year results of the GOAL study showed
that mean weight losses in men were 2.3% in the NP group
and 0.1% in the GP-UC group (P .05), while no sig-
nificant reductions were found in blood lipid levels, fast-
ing glucose levels, and BP. In women, weight change in
both groups was −1.6%. There were more individuals with
weight loss (weight losers) and stable weight (stabiliz-
ers) in the NP group than in the GP-UC group (77% vs
65%) (P .05).15
The present study reports on the long-term, 3-year re-
sults of lifestyle counseling by NPs compared with GP-UC
in overweight and obese patients at relatively “low risk”
for cardiovascular disease in preventing weight gain and
improving health status. As a secondary objective, we in-
vestigated whether the aforementioned 1-year results were




Participants were recruited (between June 2005 and February
2006) at 11 general practice locations in the northern part of
the Netherlands. As previously described in detail,15 after screen-
ing and selection, 457 participants (aged 40-70 years) were en-
rolled within a general practice setting. Eligible participants had
a BMI between 25 and 40 (calculated as weight in kilograms
divided by height in meters squared) and either hypertension
and/or dyslipidemia. Hypertension was defined as a mean sys-
tolic BP of 140 mm Hg or higher and/or a diastolic BP of 90
mm Hg or higher (based on 2 measurements on at least 2 dif-
ferent visits) or current use of BP-lowering medication, and dys-
lipidemia was defined as a total serum cholesterol level higher
than 5.5 mmol/L (to convert to milligrams per deciliter, divide
by 0.0259) or a low high-density lipoprotein cholesterol level
(HDL-C) level (male,0.9 mmol/L; female,1.1 mmol/L) or
a total cholesterol/HDL-C ratio greater than 6 and/or current
use of cholesterol level–lowering medication. Exclusion crite-
ria were diabetes mellitus, hypothyroidism, pregnancy, liver or
kidney disease, current treatment for malignant disease, se-
verely shortened life expectancy, mental illness, and addiction
to alcohol or drugs. The GOAL study was approved by the Medi-
cal Ethics Review Committee of the University Medical Cen-
ter Groningen, Groningen, the Netherlands, and written in-
formed consent was given by all participants.
MEASUREMENTS
At the GP locations, a trained research team (not blinded for
study group) performed a structured medical examination that
included measurements of body weight, length, waist circum-
ference, and BP. Body weight was measured on a digital scale
with subjects wearing light clothing and no shoes, height was
measured using a wall-mounted measuring tape, and waist cir-
cumference was measured at the level midway between the low-
est rib and the iliac crest. Blood pressure was measured twice,
and mean values were used in the analysis. The presence of car-
diovascular risk factors, medication use, and family history of
disease and overweight/obesity were documented. Blood samples
were collected in a general practice setting after an overnight
fast to analyze fasting serum lipid and glucose levels (in the
same central laboratory, LabNoord in Groningen, using con-
ventional and certified laboratory assays). Several question-
naires were completed via the Internet (as part of the software
program for the lifestyle intervention) or on paper (in case of
no Internet access). They contained questions on general char-
acteristics (eg, educational level and sex of the patient) and on
several issues related to body weight (eg, history of dieting).
The Short Questionnaire to Assess Health-Enhancing Physi-
cal Activity (SQUASH) was used to determine physical activ-
ity.16 Metabolic syndrome was defined according to criteria from
the National Cholesterol Education Program’s Adult Treat-
ment Panel III17 and Systematic Coronary Risk Evaluation
(SCORE) scores to estimate 10-year risk of fatal cardiovascu-
lar disease were calculated as described by Conroy et al.18 Base-
line data were available for all participants, with the following
exceptions: waist circumference (n=2), blood analyses (n=11),
complete questionnaires (n=11), and items in questionnaire
(range of missing items, 5%-11%). These missing baseline val-
ues are distributed equally among NP and GP-UC groups. The
measurements were performed at baseline (between January
and July 2006) after 1 and 3 years.
The number of visits in the NP and GP-UC groups was cal-
culated via the registration system from the general practice lo-
cations. This means that both visits within the study protocol
and other visits to the GP, NP, and practice assistant were in-
cluded. Only visits with 1 or more components of lifestyle coun-
seling were counted (eg, BP measurements and discussing re-
sults from blood analysis). Telephone calls and short visits were
counted as 1 visit, and long visits were counted as 2 visits. The
number of visits to a dietician during the study period was ob-
tained from a separate questionnaire for the process evalua-
tion of the study that was sent to the subjects after the 3-year
measurements (50 participants did not respond to this ques-
tionnaire).
INTERVENTION
Patients were allocated by computer-generated random num-
bers to the NP (n=225) or GP-UC (n=232) groups. The life-
style intervention consisted of 4 individual visits and 1 feed-
back session by telephone in the first year, in the next 2 years,
1 individual visit and 2 feedback sessions were planned each
year. During these contact sessions the NP is guided by the stan-
dardized computerized software program (exclusive use for the
NP group was guaranteed), which contains instructions on life-
style counseling according to national and international guide-
lines19,20 and allows data entry of the measurements. The NPs
followed a specially developed training program (5 sessions of
4 hours each: 4 sessions before the intervention and 1 session
after 1 year) and received an individual instruction about the
software program before the start of the study. The program
consisted of several elements of behavioral counseling such as
individual goal setting, monitoring using food diaries and pe-
dometers, and addressing barriers for lifestyle change. The pri-
mary aim of the intervention was to prevent weight gain and if
patients were motivated to lose 5% to 10% of body weight. The
intervention was previously described in detail.15
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The control group visited the GP after each measurement
to discuss the results, and thereafter they received usual care
according to GP guidelines.12
SAMPLE-SIZE CALCULATION
The sample-size calculation was previously described in de-
tail.15 On the basis of previous investigations, a difference in
weight loss of 2.8 kg after 1 year could be expected, resulting
in the aim to include at least 145 participants in each study arm.
The follow-up period in the next 2 years was meant to inves-
tigate the percentage of weight maintenance.
STATISTICAL ANALYSES
Differences in baseline characteristics and changes in main out-
come measures after 1 and 3 years between the 2 study groups
were evaluated with unpaired t tests for continuous variables
and2 tests for categorical variables. General linear model (GLM)
analysis was performed to adjust for baseline values in con-
tinuous variables. For lipid levels and BP, adjustments were made
for changes in cholesterol- and BP-lowering medications, re-
spectively. Logistic regression, with adjustments for baseline
fasting glucose level, was used to examine the relation be-
tween study group and the prevalence of an impaired fasting
glucose level (which is defined as a fasting glucose level6.0
mmol/L [to convert to milligrams per deciliter, divide by
0.0555]).
Furthermore, GLM analysis was used to examine the per-
centage of weight loss after 1 and 3 years in subgroups of pa-
tients. Study group, sex, and each characteristic subgroup were
separately entered in the model as fixed variables and age, base-
line BMI, and weight change between screening and baseline
as covariates. We also used GLM analysis to investigate inter-
action between patients’ sex and study group. Regainers were
defined as subjects who lost 5% of body weight or more after 1
year and returned to baseline body weight after 3 years (0%).
Subjects were categorized into the following classes according
to percentage of weight change after 1 and 3 years: successful
weight losers (lost 5%), weight losers (weight loss from 1%
to 5%), stabilizers (between 1% weight loss and 1% weight
gain) and weight gainers (gain1%). Differences in main out-
come variables between these categories were tested with analy-
sis of variance and post hoc Bonferroni test.
Results are presented with exclusion of dropouts and miss-
ing values and were adjusted for baseline values. Thereafter,
all analyses were also performed following the intention-to-
treat principle by BOCF (baseline observation carried for-
ward) for dropouts. Usually, BOCF indicates that there is no
weight change, so in our study this would mean that dropouts
were characterized as successful because they did not gain 1%
or more of their body weight. But this might be an overesti-
mation of the percentages of the participants who achieved
weight maintenance. Therefore we also performed analyses in
which all dropouts were considered as not successful, which
is probably an underestimation of the success rate. Percent-
ages of participants who achieved weight maintenance are pre-
sented as a range of both methods.
All analyses were performed in 2009 using SPSS/PC statis-
tical program version 16.0 for Windows (SPSS Inc, Chicago,
Illinois). P .05 was considered statistically significant.
RESULTS
The dropout percentage was 24% for the NP and 20%
for the GP-UC group (not significant, P=.28) (Figure).
Participants who dropped out had a higher diastolic BP
(89 vs 86 mm Hg; P=.003) and more often had a BMI of
30 or greater (reasons of dropout did not significantly
differ between participants with a BMI above or under
30); there were no differences in other characteristics be-
tween dropouts and participants who attended the fol-
low-up measurement after 3 years. Table1 gives the base-
line characteristics for both groups. Participants in the
GP-UC group more often had greater than 3 recent di-
eting attempts than in the NP group and more fre-
1378 Patients were assessed for
eligibility after prescreening
620 Provided written informed consent
825 Eligible
225 Received lifestyle counseling
from NP
232 Received usual care
from GP
201 Examined at 1-year follow-up 215 Examined at 1-year follow-up
171 Examined at 3-year follow-up 186 Examined at 3-year follow-up
553 Were excluded
381 Did not meet inclusion
criteria
172 Because of other reasons∗
30 Withdrew
04 Because of lack of time
04 Because of disease/
 mortality
02 Moved to another area
20 Because of other/unknown
 reasons
29 Withdrew
02 Because of lack of time
06 Because of disease/
 mortality
09 Moved to another area
12 Because of other/unknown
 reasons
24 Withdrew early
7 Because of lack of time
4 Would not change lifestyle
4 Because of disease/mortality
3 Moved to other area
6 Because of other/unknown
 reasons
17 Withdrew early
5 Because of lack of time
5 Because of disease/mortality
7 Because of other/unknown
 reasons
205 Refused to participate
103 Were not included because
at 1 GP location the GPs and
NPs withdrew their participation
046 Had patient-related practical
reasons for not participating
014 Were not included because of
changes in health care
insurance system
457 Randomized
Figure. Flow of patients through the Groningen Overweight and Lifestyle
(GOAL) study. GP indicates general practitioner; and NP, nurse practitioner.
*For example, not showing up at follow-up measurements during the
screening without providing a reason or not willing to participate in further
measurements like blood analyses.
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quently fulfilled the norm on physical activity (P .05
for both).
CHANGES IN MAIN OUTCOME
MEASURES AFTER 3 YEARS
After 3 years, no differences in mean (SD) weight change
were present between the NP and GP-UC groups (NP,
−1.2% [5.8%]; GP-UC: −0.6% [5.6%]; P=.37). Approxi-
mately 60% of the participants in both groups were weight
losers or stabilizers after 3 years (Table 2).
In the NP group, a positive effect was found on mean
(SD) fasting glucose level at the 3-year follow-up com-
pared with the GP-UC group (−0.02 [0.49]) mmol/L vs
0.10 (0.53) mmol/L; P=.02). After 3 years the preva-
lence of impaired fasting glucose level was 6% (n=10)
in the NP group vs 12% (n=21) in the GP-UC group
(P=.17) (Table 2). In persons with a BMI of 30 or greater,
the prevalence was lower in the NP than in the GP-UC
group (7% [n=4] vs 22% [n=14]) but was not signifi-
cant after adjustment for baseline values (P=.14) (data
not shown). No significant differences between the NP
and GP-UC groups occurred for serum lipid levels and
BP at the 3-year follow-up (Table 2).
CHANGES IN MAIN OUTCOME MEASURES
AFTER 3 YEARS COMPARED WITH 1 YEAR
Contrary to the results after 3 years, the percentage of
mean (SD) weight loss after 1 year differed between the
NP and GP-UC groups (NP group, −2.2% [7.0%]; GP-UC
group, −0.7% [4.6%]; P=.002), and there were more
weight losers and stabilizers after 1 year in the NP group
than in the GP-UC group (80% vs 64%; P= .001)
(Table 3). The percentage of regainers in the NP group
was comparable to the GP-UC group (14% and 16%, re-
spectively) (Table 2).
WEIGHT LOSS AFTER 3 YEARS
BETWEEN AND WITHIN SUBGROUPS
There were no differences in weight change after 3 years
between the NP and GP-UC groups in subgroups of pa-
tients’ characteristics at baseline (Table 3). Interaction







Age, mean (SD), y 55.3 (7.7) 56.9 (7.8)
Men, No. (%) 113 (50.2) 107 (46.1)
Low education, No./total (%)a 71/212 (33.5) 67/217 (30.9)
Relationship, No./total (%)b 177/213 (83.1) 188/226 (85.5)
Physical examination and blood analysis
Body weight, mean (SD), kg 88.2 (12.1) 87.8 (14.0)
BMI, mean (SD) 29.5 (3.1) 29.6 (3.6)
BMI 30, No. (%) 79 (35.1) 85 (36.6)
Waist circumference for men, mean (SD), cm 104 (7.8) 105 (9.5)
Waist circumference for women, mean (SD), cm 97 (9.8) 97 (11.8)
Total cholesterol, mean (SD), mmol/L 5.66 (1.0) 5.56 (1.0)
HDL-C, mean (SD), mmol/L 1.44 (0.4) 1.43 (0.4)
LDL-C, mean (SD), mmol/L 3.50 (0.9) 3.43 (0.9)
Fasting glucose, mean (SD), mmol/L 5.20 (0.5) 5.25 (0.7)
Impaired fasting glucose, No./total (%)c 14/219 (6) 20/226 (9)
Systolic BP, mean (SD), mm Hg 146 (18.5) 145 (15.5)
Diastolic BP, mean (SD), mm Hg 87 (9.6) 86 (8.2)
Hypertension, No. (%) 137 (60.9) 145 (62.5)
Using medication for hypertension, No./total (%)d 61/136 (44.9) 74/144 (51.4)
Dyslipidemia, No. (%) 83 (36.9) 96 (41.4)
Using medication for dyslipidemia, No./total (%)e 31/83 (37.3) 43/96 (44.8)
SCORE score, mean (SD) 3.55 (4.0) 3.29 (3.0)
SCORE score 5, No./total (%) 175/219 (79.9) 182/226 (80.5)
Metabolic syndrome, No./total (%) 98/224 (43.8) 102/232 (44.0)
Lifestyle
Current smokers, No./total (%) 46/224 (20.5) 42/232 (18.1)
3 Attempts to lose weight during last 5 y, No./total (%) 33/207 (15.9) 55/213 (25.8f)
30 Minutes of moderate-intensity physical activity, 5 d/wk, No./total (%) 123/216 (56.9) 150/220 (68.2f)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); BP, blood pressure; GP-UC, usual care by a
general practitioner; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NP, nurse practitioner; SCORE, Systematic Coronary
Risk Evaluation.
Conventional unit conversion factors: To convert cholesterol and glucose to milligrams per deciliter, divide by 0.0259 and 0.0555, respectively.
aPercentage of participants with a lower professional education or less.
bPercentage of participants who were married or living together with a partner.
c Fasting glucose level higher than 6 mmol/L.
dPercentage of participants with hypertension.
ePercentage of participants with dyslipidemia.
fNP vs GP-UC group P .05 (² test).
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between sex and study group was absent. Within the NP
group, participants with 3 or fewer attempts to lose weight
during the last 5 years lost more weight after 3 years than
participants with 4 or more attempts (P .05). These par-
ticipants gained 1.4% (95% confidence interval, −0.9 to
3.7) of their baseline weight after 3 years.
CHANGES IN MAIN OUTCOME VARIABLES
AFTER 3 YEARS STRATIFIED
BY WEIGHT LOSS CATEGORIES
Successful weight losers achieved the most favorable re-
sults and weight gainers the least favorable results after
3 years on physiological outcome variables except for sys-
tolic BP (Table 4). After 3 years, stabilizers and weight
gainers (n=192) achieved significantly better results for
mean (SD) fasting glucose level (0.10 [0.50] mmol/L) than
regainers (0.57 [0.60] mmol/L) (P=.008) but not for lipid
levels and BP (data not shown).
INTENTION-TO-TREAT ANALYSIS
Intention-to-treat analysis did not substantially alter the
results after 3 years. For example, mean (SD) weight loss
after 3 years in the NP group was −0.8% (5.0%) and −0.5%
(5.0%) in the GP-UC group (P=.45). Change in mean
(SD) low-density lipoprotein cholesterol (LDL-C) level
did not differ between the NP and GP-UC groups (NP
group, 0.15 [0.71] mmol/L; GP-UC group, 0.04 [0.77]
mmol/L; P=.11). Change in mean (SD) fasting glucose
level after 3 years differed significantly between the NP
and GP-UC groups (−0.01 [0.43] mmol/L vs 0.08 [0.47]
mmol/L, respectively; P=.03). The percentages of par-
ticipants who achieved weight maintenance varied from
47% to 71% in the NP group and from 51% to 71% in
the GP-UC group (depending on whether dropouts are
considered successful or not).
COMMENT
The design of our study was different from several other
published weight intervention studies because we fo-
cused on weight maintenance in persons with a rela-
tively low mean BMI (almost 30) and because we had a
considerably longer follow-up than in most other stud-
ies, within a “realistic” primary care setting. The rel-
evance of prolonged follow-up is reflected by the differ-
ences between the 1-year and the somewhat disappointing
3-year results on weight maintenance. After 1 year, 80%
of the participants in the NP group indeed achieved weight
maintenance vs 64% in the GP-UC group. However, af-
ter 3 years, differences between both groups had disap-
peared: with 60% success in weight maintenance of the
participants in both groups. Changes in fasting glucose
levels differed in favor of the NP group, especially among
obese persons the prevalence of an impaired fasting glu-
cose level differed considerably after 3 years (7% vs 22%),
but owing to lack of power in this subgroup analysis, this
result was not significant when adjusted for baseline val-
ues (P=.14).
In comparison with other studies with prolonged fol-
low-up, Jeffery and French21 described a weight gain of
approximately 1.5 kg after 3 years for treatment and con-
trol groups, but they used a low-intensity intervention
mostly conducted by mail. Another randomized con-
trolled trial with a longer follow-up of 54 months was
reported by Simkin-Silverman et al,22 but this was done
Table 2. Changesa in Main Outcome Measures at 1- and 3-Year Follow-up in the NP and GP-UC Groups
Main Outcome Measure
1-y Follow-up 3-y Follow-up
No. NP Group No. GP-UC Group P Value No. NP Group No. GP-UC Group P Value
Body weight, mean (SD), kg 171 −2.0 (4.3) 186 −0.6 (4.0) .002 171 −1.1 (5.3) 186 −0.5 (5.0) .34
Body weight, mean (SD), % change 171 −2.2 (4.6) 186 −0.7 (4.6) .002 171 −1.2 (5.8) 186 −0.6 (5.6) .37
BMI, mean (SD) 171 −0.7 (1.4) 186 −0.2 (1.4) .002 171 −0.4 (1.8) 186 −0.2 (1.7) .31
Waist circumference, mean (SD), cm 169 −2.6 (7.0) 186 −1.1 (5.8) .03 169 −0.8 (7.1) 182 0.4 (7.2) .11
Total cholesterol, mean (SD), mmol/L 164 −0.10 (0.75) 181 −0.06 (0.71) .50 164 0.07 (0.92) 178 −0.05 (0.93) .15
HDL-C, mean (SD), mmol/L 164 −0.08 (0.22) 181 −0.09 (0.22) .61 164 −0.17 (0.26) 178 −0.17 (0.25) .75
LDL-C, mean (SD), mmol/L 162 0.04 (0.68) 179 0.05 (0.65) .63 160 0.20 (0.81) 176 0.05 (0.86) .09
Fasting glucose, mean (SD), mmol/L 163 −0.08 (0.48) 181 −0.06 (0.45) .46 162 −0.02 (0.49) 176 0.10 (0.53) .02b
Impaired fasting glucose, No. (%)c 163 8 (5) 181 13 (7) .70 162 10 (6) 176 21 (12) .17
Systolic BP, mean (SD), mm Hg 171 −7.0 (18.6) 186 −3.3 (15.3) .03 171 −5.9 (17.3) 186 −3.8 (14.5) .38
Diastolic BP, mean (SD), mm Hg 171 −1.5 (10.2) 186 −0.3 (8.1) .20 171 −2.0 (10.8) 186 −1.1 (9.3) .41
Weight losers/stabilizers, No. (%)d 171 136 (80) 186 119 (64) .001 171 106 (62) 186 118 (63) .78
Regainers, No. (%)e 37f 5 (14) 31f 5 (16) .76
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); BP, blood pressure; GP-UC, usual care by a
general practitioner; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NP, nurse practitioner.
Conventional unit conversion factors: To convert cholesterol and glucose to milligrams per deciliter, divide by 0.0259 and 0.0555, respectively.
aChanges are calculated as the value at 1- or 3-year follow-up minus the value at baseline, and adjusted for baseline values (for lipids and blood pressure, for
changes in cholesterol- and BP-lowering medications, respectively).
bAdjustments for differences between the NP and the GP-UC groups on baseline characteristics (physical activity and number of recent attempts to lose weight)
did not alter this result.
cFasting glucose level higher than 6 mmol/L, P values: logistic regression adjusted for baseline values.
dPercentage of subjects who gained less than 1% of body weight between baseline and 1- or 3-year measurement.
ePercentage of subjects who lost 5% of body weight or more after 1 year and returned to baseline body weight after 3 years (0%).
f Number of subjects who lost 5% of body weight or more after 1 year.
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Table 3. Percentage Change in Body Weight at 1- and 3-Year Follow-up, Stratified by Subgroups of Patients’ Characteristics




NP Group % Change
in Body Weight (95% CI)a
GP-UC Group % Change
in Body Weight (95% CI)a
1-y Follow-up 3-y Follow-up No. 1-y Follow-up 3-y Follow-up
Total, uncorrected 171 −2.2 (−2.9 to −1.5)b −1.2 (−2.0 to −0.3) 186 −0.7 (−1.3 to −0.0) −0.6 (−1.4 to 0.2)
Total, adjusteda 170 −2.2 (−2.9 to −1.5)b −1.2 (−2.1 to −0.4) 185 −0.7 (−1.4 to −0.0) −0.5 (−1.3 to 0.3)
Sex
Men 84 −2.3 (−3.2 to −1.3)b −1.4 (−2.6 to −0.1) 82 −0.1 (−1.1 to 0.9) −0.2 (−1.4 to 0.9)
Women 86 −2.1 (−3.2 to −1.2) −0.9 (−2.2 to 0.3) 103 −1.1 (−2.0 to −0.3) −0.9 (−1.9 to 0.2)
Age, y
60 117 −2.6 (−3.5 to −1.8)b −0.8 (−1.9 to 0.2) 110 −0.5 (−1.4 to 0.4) 0.0 (−1.1 to 1.1)
60 53 −1.4 (−2.6 to −0.1) −1.8 (−3.4 to −0.3) 75 −0.8 (−1.9 to 0.3) −1.4 (−2.7 to −0.1)
Education
Low 56 −3.0 (−4.3 to −1.7) −1.2 (−2.8 to 0.3) 56 −1.2 (−2.4 to 0.1) −0.4 (−1.9 to 1.1)
Other 106 −1.9 (−2.8 to −1.0)b −1.1 (−2.3 to −0.0) 119 −0.3 (−1.1 to 0.5) −0.7 (−1.7 to 0.3)
BMI
30 113 −1.7 (−2.5 to −0.8)c −0.7 (−1.7 to 0.4) 121 −0.6 (−1.4 to 0.3) −0.3 (−1.3 to 0.7)
30 57 −3.3 (−4.5 to −2.1)b −2.1 (−3.6 to −0.6) 64 −0.8 (−2.0 to 0.4) −1.1 (−2.6 to 0.3)
Attempts to lose weight during last 5 y
3 times 131 −2.6 (−3.4 to −1.8)b,c −1.5 (−2.5 to −0.5)c 125 −0.4 (−1.3 to 0.4) −0.5 (−1.5 to 0.5)
3 times 26 −0.0 (−1.9 to 1.8) 1.4 (−0.9 to 3.7) 47 −1.1 (−2.5 to 0.3) −0.7 (−2.5 to 1.0)
Treatment recommendedd
Yes 159 −2.4 (−3.1 to −1.7)b −1.2 (−2.1 to −0.3) 171 −0.6 (−1.3 to 0.1) −0.5 (−1.3 to 0.3)
No 11 0.1 (−2.7 to 3.0) 0.2 (−3.3 to 3.7) 14 −1.3 (−3.8 to 1.2) −1.3 (−4.2 to 1.7)
No. of visitse
Mean 108f −2.3 (−3.2 to −1.4) −1.6 (−2.7 to −0.5) 126f −0.5 (−1.3 to 0.3) −0.4 (−1.4 to 0.6)
Mean 62f −2.1 (−3.3 to −0.9) −0.5 (−1.8 to 0.9) 58f −0.9 (−2.2 to 0.3) −1.0 (−2.4 to 0.5)
Visiting a dietician
No 116 −1.6 (−2.7 to −0.6) 152 −1.8 (−1.6 to 0.1)
Yes 20 −0.1 (−2.5 to 2.8) 17 −0.4 (−3.1 to 2.3)
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CI, confidence interval; GP-UC, usual care by a
general practitioner; NP, nurse practitioner.
aChanges are calculated as the value at 1- or 3-year follow-up minus the value at baseline and adjusted for sex, age, BMI at baseline, and weight change
between screening and baseline (for 1 man in the intervention group and 1 man in the control group, screening data were missing).
bP .05, NP vs GP-UC group.
cP .05 within NP or GP-UC group.
dTreatment for overweight/obesity was indicated according to national and international guidelines19,20 (motivation of patient not taken into account).
eSeparately for the NP group (mean after 1 year, 10 visits; mean after 3 years, 18 visits) and the GP-UC group (mean after 1 year, 2 visits; mean after 3 years,
4 visits).
f After 3 years, NP group (mean, n=100; mean, n=70) and GP-UC group ( mean, n=123; mean, n=61).











Body weight, mean (SD), kg −8.4 (4.5) −2.3 (1.0)c −0.1 (0.4)c 3.8 (2.6)c .001
Body weight, mean (SD), % change −9.3 (4.2) −2.7 (1.0)c −0.1 (0.5)c 4.4 (2.9)c .001
Waist circumference, mean (SD), cm −7.0 (8.1) −1.2 (6.2)c 0.4 (4.9)c 3.7 (5.0)c .001
Total cholesterol, mean (SD), mmol/L −0.23 (0.94) 0.02 (0.93) 0.05 (0.78) 0.11 (0.95)d .009
HDL-C, mean (SD), mmol/L −0.11 (0.27) −0.17 (0.30) −0.13 (0.23) −0.22 (0.22)d .02
LDL-C, mean (SD), mmol/L −0.14 (0.92) 0.16 (0.85) 0.16 (0.62) 0.22 (0.87)d .008
Fasting glucose, mean (SD), mmol/L −0.11 (0.54) −0.03 (0.46) 0.13 (0.52)d 0.12 (0.52)d .001
Systolic BP, mean (SD), mm Hg −7.3 (17.2) −3.3 (16.5) −7.9 (13.6) −2.9 (15.6) .25
Diastolic BP, mean (SD), mm Hg −4.7 (10.0) −1.2 (10.1) −2.5 (7.9) 0.5 (10.6)c .002
Abbreviations: ANOVA, analysis of variance; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); BP, blood pressure;
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Conventional unit conversion factors: To convert cholesterol and glucose to milligrams per deciliter, divide by 0.0259 and 0.0555, respectively.
aChanges are calculated as the value at 3-year follow-up minus the value at baseline.
bP value for linear trend.
cP .01, ANOVA with post hoc Bonferroni test with “successful weight losers” as reference category.
dP .05, ANOVA with post hoc Bonferroni test with “successful weight losers” as reference category.
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in postmenopausal women with normal weight and car-
diovascular risk and showed that weight maintenance is
possible with a lifestyle intervention. It is notable that
we found a small difference in the fasting glucose level,
while in the Diabetes Prevention Study, differences be-
tween intervention and control groups were absent for
fasting glucose levels, although significant differences in
weight change did occur.6 Other studies have shown that
changes in lifestyle without losing weight can improve
health status.7,8
Most of the participants in both groups achieved weight
maintenance. Several factors may be responsible for the
long-term lack of difference that we expected between
the NP and GP-UC groups. Patients in the GP-UC group
may be more adherent to advice given by the GP be-
cause of the study circumstances. In line with the ethi-
cal committee demands, all patients were fully in-
formed about the study purpose, and hence they knew
beforehand that body weight was assessed as well as ad-
herence to lifestyle advice. This in itself may, through some
kind of Hawthorne effect, lead to modified behavior so
that all patients were more adherent than they might have
been under other circumstances, and this may have di-
luted any differences between the groups. Moreover, both
groups in this trial comprised volunteers and were thus
a selection of motivated patients.
The attention on health (and body weight) during the
measurements in combination with abundant country-
wide campaigns for a healthy lifestyle held during the course
of the study may, besides the visits to the GP, also have been
responsible for lifestyle changes in the control group. In
comparison with the Dutch population, where an average
increase in BMI of 0.05 per year (between 1981 and 2004)
was described by Gast et al,23 we found a decrease of −0.4
in the NP group and −0.2 in the GP-UC group. Thus, we
can consider that the majority in the NP and GP-UC groups
succeeded in preventing (further) weight gain.
Besides the limitations like baseline differences be-
tween NP and GP-UC groups and randomization at a pa-
tient level instead of at a practice level, as previously de-
scribed in detail,15 another limitation of the GOAL study
needs to be discussed. The visits to the NP after the first
year occurred at a low frequency and may not be suffi-
cient to sustain weight loss. Overall, in both groups,
achieving weight maintenance was not influenced by the
mean number of visits (Table 3). In the Diabetes Pre-
vention Study, 4 face-to-face visits each year were sched-
uled after the first year to achieve sustained weight loss
after 3 years.6 Bogers et al24 also described that higher in-
tervention costs (indicative for the intensity of an inter-
vention) are associated with greater weight loss. Al-
though this association with weight loss was determined
after 1 year, it is plausible that it will also apply for long-
term weight loss.
In intention-to-treat analysis regarding weight change,
we chose a conservative way to deal with the dropouts
by carrying the baseline observation forward. This means
that we assumed that dropouts during the intervention
lost no weight or regained all the weight that might be
lost in the first year of the intervention and thereby pos-
sibly underestimated the weight loss of the dropouts in
both groups.
The strengths of our study are the large study popu-
lation with an equal amount of male and female partici-
pants, a relatively low dropout after 3 years, the pro-
longed follow-up, and the use of an intervention that is
feasible in a primary care setting. The software program
can easily be used at other locations, and the interven-
tion is not time intensive and expensive. More research
is planned to evaluate the process of the GOAL inter-
vention, which is useful for further implementation.
Analyses in subgroups showed that within the NP
group participants with 3 or fewer recent attempts to
lose weight had a lower weight after 3 years compared
with participants with more than 3 attempts. The lat-
ter participants’ mean weight gain was 1.4% (95% con-
fidence interval, −0.9% to 3.7%). This means that our
intervention is not suitable for experienced dieters.
Regainers achieved unfavorable results on fasting glu-
cose levels compared with stabilizers and weight gain-
ers, which is in line with other negative health effects of
weight cycling that were described.25-27 No clear results
have been reported on the relation between repeated
weight losses and mortality and the underlying mecha-
nisms.28-31
We can conclude that preventing weight gain by NPs
did not lead to significantly better results than by GPs.
More follow-up sessions in the NP group may lead to a
higher percentage of maintenance of the weight that was
lost after 1 year.
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INVITED COMMENTARY
Is Primary Care Practice Equipped to Deal
With Obesity?
O besity is associated with a long list of seriousmedical complications that impair health,reduce quality of life, and shorten lifespan.1
These complications can be improved or completely
resolved by weight loss. Therefore, obesity is a legiti-
mate medical concern that should involve the imple-
mentation of therapeutic weight loss by primary prac-
tice physicians. However, an evaluation of a large
primary care database in the United States found that
only 20% of obese patients were given a diagnosis of
obesity, and only 40% of those patients were given an
obesity management plan.2 These data suggest that gen-
eral medical practices are not addressing the issue of
weight management in obese patients.
In this issue, ter Bogt and colleagues report the
results of a randomized controlled trial that evaluated
the effect of lifestyle counseling, provided by trained
NPs within a primary care setting, on long-term weight
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